1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Farooq, A.
Zhou, M.-M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure
STRUE6
2005
0969-2126
11
155
164
10.1016/S0969-2126(02)00943-7
12575935
Solution Structure of the MAPK Phosphatase PAC-1 Catalytic Domain Insights into Substrate-Induced Enzymatic Activation of MKP
2003
10.2210/pdb1m3g/pdb
pdb_00001m3g
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
16129.417
DUAL SPECIFICITY PROTEIN PHOSPHATASE 2
3.1.3.48, 3.1.3.16
CATALYTIC DOMAIN, RESIDUES 170-314
C257S
1
man
polymer
MAPK Phosphatase PAC-1, DUAL SPECIFICITY PROTEIN PHOSPHATASE PAC-1
no
no
QGGPVEILPYLFLGSCSHSSDLQGLQACGITAVLNVSASCPNHFEGLFRYKSIPVEDNQMVEISAWFQEAIGFIDWVKNS
GGRVLVHSQAGISRSATICLAYLMQSRRVRLDEAFDFVKQRRGVISPNFSFMGQLLQFETQVLCH
QGGPVEILPYLFLGSCSHSSDLQGLQACGITAVLNVSASCPNHFEGLFRYKSIPVEDNQMVEISAWFQEAIGFIDWVKNS
GGRVLVHSQAGISRSATICLAYLMQSRRVRLDEAFDFVKQRRGVISPNFSFMGQLLQFETQVLCH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
plasmid
pET15b
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2003-06-27
1
1
2008-04-28
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
2004-02-03
SPRSDE
RCSB
Y
RCSB
2002-06-27
REL
THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY
200
1
3D_13C-SEPARATED_NOESY
3D_ 15N-SEPARATED_NOESY
HNHA
10
6.5
1
atm
298
K
simulated annealing
0.5MM CATALYTIC DOMAIN MAPK PHOSPHATASE U-15N,13C; 5MM PHOSPHATE BUFFER PH 6.5
BRUNGER (X-PLOR), NILGES, O'DONOGHUE (ARIA)
structure solution
XPLOR/ARIA
collection
XwinNMR
processing
NMRPipe
data analysis
NMRView
BRUNGER (X-PLOR)/ NILGES, O'DONOGHUE (ARIA)
refinement
XPLOR/ARIA
500
Bruker
DRX
600
Bruker
DRX
GLN
170
n
1
GLN
170
A
GLY
171
n
2
GLY
171
A
GLY
172
n
3
GLY
172
A
PRO
173
n
4
PRO
173
A
VAL
174
n
5
VAL
174
A
GLU
175
n
6
GLU
175
A
ILE
176
n
7
ILE
176
A
LEU
177
n
8
LEU
177
A
PRO
178
n
9
PRO
178
A
TYR
179
n
10
TYR
179
A
LEU
180
n
11
LEU
180
A
PHE
181
n
12
PHE
181
A
LEU
182
n
13
LEU
182
A
GLY
183
n
14
GLY
183
A
SER
184
n
15
SER
184
A
CYS
185
n
16
CYS
185
A
SER
186
n
17
SER
186
A
HIS
187
n
18
HIS
187
A
SER
188
n
19
SER
188
A
SER
189
n
20
SER
189
A
ASP
190
n
21
ASP
190
A
LEU
191
n
22
LEU
191
A
GLN
192
n
23
GLN
192
A
GLY
193
n
24
GLY
193
A
LEU
194
n
25
LEU
194
A
GLN
195
n
26
GLN
195
A
ALA
196
n
27
ALA
196
A
CYS
197
n
28
CYS
197
A
GLY
198
n
29
GLY
198
A
ILE
199
n
30
ILE
199
A
THR
200
n
31
THR
200
A
ALA
201
n
32
ALA
201
A
VAL
202
n
33
VAL
202
A
LEU
203
n
34
LEU
203
A
ASN
204
n
35
ASN
204
A
VAL
205
n
36
VAL
205
A
SER
206
n
37
SER
206
A
ALA
207
n
38
ALA
207
A
SER
208
n
39
SER
208
A
CYS
209
n
40
CYS
209
A
PRO
210
n
41
PRO
210
A
ASN
211
n
42
ASN
211
A
HIS
212
n
43
HIS
212
A
PHE
213
n
44
PHE
213
A
GLU
214
n
45
GLU
214
A
GLY
215
n
46
GLY
215
A
LEU
216
n
47
LEU
216
A
PHE
217
n
48
PHE
217
A
ARG
218
n
49
ARG
218
A
TYR
219
n
50
TYR
219
A
LYS
220
n
51
LYS
220
A
SER
221
n
52
SER
221
A
ILE
222
n
53
ILE
222
A
PRO
223
n
54
PRO
223
A
VAL
224
n
55
VAL
224
A
GLU
225
n
56
GLU
225
A
ASP
226
n
57
ASP
226
A
ASN
227
n
58
ASN
227
A
GLN
228
n
59
GLN
228
A
MET
229
n
60
MET
229
A
VAL
230
n
61
VAL
230
A
GLU
231
n
62
GLU
231
A
ILE
232
n
63
ILE
232
A
SER
233
n
64
SER
233
A
ALA
234
n
65
ALA
234
A
TRP
235
n
66
TRP
235
A
PHE
236
n
67
PHE
236
A
GLN
237
n
68
GLN
237
A
GLU
238
n
69
GLU
238
A
ALA
239
n
70
ALA
239
A
ILE
240
n
71
ILE
240
A
GLY
241
n
72
GLY
241
A
PHE
242
n
73
PHE
242
A
ILE
243
n
74
ILE
243
A
ASP
244
n
75
ASP
244
A
TRP
245
n
76
TRP
245
A
VAL
246
n
77
VAL
246
A
LYS
247
n
78
LYS
247
A
ASN
248
n
79
ASN
248
A
SER
249
n
80
SER
249
A
GLY
250
n
81
GLY
250
A
GLY
251
n
82
GLY
251
A
ARG
252
n
83
ARG
252
A
VAL
253
n
84
VAL
253
A
LEU
254
n
85
LEU
254
A
VAL
255
n
86
VAL
255
A
HIS
256
n
87
HIS
256
A
SER
257
n
88
SER
257
A
GLN
258
n
89
GLN
258
A
ALA
259
n
90
ALA
259
A
GLY
260
n
91
GLY
260
A
ILE
261
n
92
ILE
261
A
SER
262
n
93
SER
262
A
ARG
263
n
94
ARG
263
A
SER
264
n
95
SER
264
A
ALA
265
n
96
ALA
265
A
THR
266
n
97
THR
266
A
ILE
267
n
98
ILE
267
A
CYS
268
n
99
CYS
268
A
LEU
269
n
100
LEU
269
A
ALA
270
n
101
ALA
270
A
TYR
271
n
102
TYR
271
A
LEU
272
n
103
LEU
272
A
MET
273
n
104
MET
273
A
GLN
274
n
105
GLN
274
A
SER
275
n
106
SER
275
A
ARG
276
n
107
ARG
276
A
ARG
277
n
108
ARG
277
A
VAL
278
n
109
VAL
278
A
ARG
279
n
110
ARG
279
A
LEU
280
n
111
LEU
280
A
ASP
281
n
112
ASP
281
A
GLU
282
n
113
GLU
282
A
ALA
283
n
114
ALA
283
A
PHE
284
n
115
PHE
284
A
ASP
285
n
116
ASP
285
A
PHE
286
n
117
PHE
286
A
VAL
287
n
118
VAL
287
A
LYS
288
n
119
LYS
288
A
GLN
289
n
120
GLN
289
A
ARG
290
n
121
ARG
290
A
ARG
291
n
122
ARG
291
A
GLY
292
n
123
GLY
292
A
VAL
293
n
124
VAL
293
A
ILE
294
n
125
ILE
294
A
SER
295
n
126
SER
295
A
PRO
296
n
127
PRO
296
A
ASN
297
n
128
ASN
297
A
PHE
298
n
129
PHE
298
A
SER
299
n
130
SER
299
A
PHE
300
n
131
PHE
300
A
MET
301
n
132
MET
301
A
GLY
302
n
133
GLY
302
A
GLN
303
n
134
GLN
303
A
LEU
304
n
135
LEU
304
A
LEU
305
n
136
LEU
305
A
GLN
306
n
137
GLN
306
A
PHE
307
n
138
PHE
307
A
GLU
308
n
139
GLU
308
A
THR
309
n
140
THR
309
A
GLN
310
n
141
GLN
310
A
VAL
311
n
142
VAL
311
A
LEU
312
n
143
LEU
312
A
CYS
313
n
144
CYS
313
A
HIS
314
n
145
HIS
314
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
VAL
174
A
N
VAL
5
A
O
LEU
182
A
O
LEU
13
A
N
PHE
181
A
N
PHE
12
A
O
VAL
253
A
O
VAL
84
A
O
LEU
254
A
O
LEU
85
A
N
LEU
203
A
N
LEU
34
A
N
VAL
202
A
N
VAL
33
A
O
ARG
218
A
O
ARG
49
A
O
TYR
219
A
O
TYR
50
A
N
PHE
213
A
N
PHE
44
1
A
LEU
177
54.38
174.85
1
A
SER
184
-172.23
-63.09
1
A
CYS
185
-110.80
-151.57
1
A
THR
200
-124.02
-61.68
1
A
ASN
204
-68.56
90.86
1
A
VAL
205
-69.85
78.50
1
A
SER
206
-125.34
-77.30
1
A
ALA
207
-170.88
-143.58
1
A
CYS
209
50.29
-175.58
1
A
PRO
210
-57.92
84.99
1
A
HIS
212
-116.49
74.40
1
A
GLU
214
-175.10
59.35
1
A
PHE
217
-168.56
-79.06
1
A
GLN
228
55.03
-87.89
1
A
MET
229
-149.21
27.92
1
A
VAL
230
53.71
101.37
1
A
SER
249
-149.99
-49.68
1
A
GLN
258
-155.02
21.43
1
A
ALA
259
-173.05
29.85
1
A
ARG
279
55.68
165.93
1
A
LYS
288
-171.11
-171.28
1
A
ARG
290
-64.12
-154.53
1
A
ARG
291
54.58
95.97
1
A
SER
295
54.29
173.83
1
A
PRO
296
-63.88
99.80
1
A
ASN
297
-162.38
39.27
1
A
LEU
304
-157.83
-69.20
1
A
LEU
312
-88.90
-74.37
SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF MAPK PHOSPHATASE PAC-1: INSIGHTS INTO SUBSTRATE-INDUCED ENZYMATIC ACTIVATION
1
N
N
A
HIS
187
A
HIS
18
HELX_P
A
GLY
198
A
GLY
29
1
1
12
A
TRP
235
A
TRP
66
HELX_P
A
SER
249
A
SER
80
1
2
15
A
SER
262
A
SER
93
HELX_P
A
SER
275
A
SER
106
1
3
14
A
VAL
278
A
VAL
109
HELX_P
A
LYS
288
A
LYS
119
1
4
11
A
LEU
304
A
LEU
135
HELX_P
A
LEU
312
A
LEU
143
1
5
9
HYDROLASE
CATALYTIC DOMAIN, MAPK PHOSPHATASE, PAC-1, HYDROLASE
DUS2_HUMAN
UNP
1
1
Q05923
MGLEAARELECAALGTLLRDPREAERTLLLDCRPFLAFCRRHVRAARPVPWNALLRRRARGPPAAVLACLLPDRALRTRL
VRGELARAVVLDEGSASVAELRPDSPAHVLLAALLHETRAGPTAVYFLRGGFDGFQGCCPDLCSEAPAPALPPTGDKTSR
SDSRAPVYDQGGPVEILPYLFLGSCSHSSDLQGLQACGITAVLNVSASCPNHFEGLFRYKSIPVEDNQMVEISAWFQEAI
GFIDWVKNSGGRVLVHCQAGISRSATICLAYLMQSRRVRLDEAFDFVKQRRGVISPNFSFMGQLLQFETQVLCH
170
314
1M3G
170
314
Q05923
A
1
1
145
1
CYS
engineered mutation
SER
257
1M3G
A
Q05923
UNP
257
88
6
anti-parallel
parallel
parallel
parallel
anti-parallel
A
VAL
174
A
VAL
5
A
ILE
176
A
ILE
7
A
LEU
180
A
LEU
11
A
LEU
182
A
LEU
13
A
VAL
253
A
VAL
84
A
VAL
255
A
VAL
86
A
ALA
201
A
ALA
32
A
ASN
204
A
ASN
35
A
ARG
218
A
ARG
49
A
SER
221
A
SER
52
A
ASN
211
A
ASN
42
A
PHE
213
A
PHE
44